UPDATED May 02, 2024
Discover Canadian Pharmaceuticals & Biotech Growth Stocks that are on the TSX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
YOUR | CA$0.085 | 0% | -65.3% | CA$23.2m | n/a | PE6x | n/a | n/a | ||
THC | CA$0.02 | 0% | -50.0% | CA$3.3m | n/a | PS1.5x | n/a | n/a | ||
PILL | n/a | n/a | n/a | CA$194.5k | n/a | n/a | n/a | n/a | ||
CANN | CA$0.005 | 0% | -66.7% | CA$5.1m | n/a | PB0.2x | n/a | n/a | ||
SOL | CA$0.04 | -11.1% | -42.9% | CA$2.2m | n/a | PB0.3x | n/a | n/a | ||
ENBI | CA$0.17 | 6.5% | -34.0% | CA$1.5m | n/a | PS11.2x | n/a | n/a | ||
NOVA | CA$0.015 | 0% | -70.0% | CA$2.2m | n/a | PE-1.8x | n/a | n/a | ||
TMED | CA$0.14 | 0% | -65.0% | CA$1.6m | n/a | PE-4.9x | n/a | n/a | ||
VXL | CA$0.01 | 0% | -33.3% | CA$1.4m | n/a | PB1.5x | n/a | n/a | ||
MPH | CA$1.07 | 4.9% | 5.9% | CA$11.2m | n/a | PB0.6x | n/a | n/a | ||
NAV | CA$0.03 | -14.3% | -68.4% | CA$2.0m | n/a | PE-0.7x | n/a | n/a | ||
HERB | CA$0.05 | 11.1% | 0% | CA$4.0m | n/a | PB0.9x | n/a | n/a | ||
PLTH | CA$0.87 | 2.4% | -12.1% | CA$216.5m | CA$1.96 | PS1.6x | n/a | n/a | ||
TELI | CA$0.32 | -10.0% | 125.0% | CA$17.7m | n/a | PS4.6x | n/a | n/a | ||
IAN | CA$0.03 | 20.0% | 50.0% | CA$165.4m | n/a | PE-1.9x | n/a | n/a | ||
ACOG | CA$0.68 | 0% | 223.8% | CA$100.6m | CA$1.00 | PE-5.4x | n/a | n/a | ||
QPT | CA$0.03 | 50.0% | -60.0% | CA$5.1m | n/a | PB0.08x | n/a | n/a | ||
LOVE | CA$0.80 | -5.9% | -2.4% | CA$74.7m | n/a | PE11.6x | n/a | n/a | ||
GWAY | CA$0.31 | -8.8% | 37.8% | CA$43.3m | n/a | PS8x | n/a | n/a | ||
SE | CA$0.035 | -30.0% | -65.0% | CA$640.1k | n/a | PS13.6x | n/a | n/a | ||
CTX | CA$0.43 | 0% | -35.8% | CA$8.4m | n/a | PB0.4x | n/a | n/a | ||
SLNG | CA$0.04 | 14.3% | 33.3% | CA$9.1m | n/a | PE-0.5x | n/a | n/a | ||
VEXT | CA$0.33 | 40.4% | 13.8% | CA$77.3m | n/a | PE11.7x | S31.3% | n/a | ||
IKNK.U | US$0.22 | 0% | n/a | US$49.5m | n/a | n/a | n/a | n/a |